Frontlight ResearchEarly access
Triple-negative breast cancer trials in Italy
4 of 31 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleRole of Tumor Microbiota in the Response to Neoadjuvant Therapy in Patients Affected by Triple Negative Breast Cancer
- Where
- Pavia
- Age
- 18 years and over
- People
- 30
- Run by
- Istituti Clinici Scientifici Maugeri SpA
See details and how to joinNCT07808086 - No phaseTaking peopleBiomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study
- Where
- Rome
- Age
- 18 years and over
- People
- 60
- Run by
- Regina Elena Cancer Institute
See details and how to joinNCT06240195 - No phaseTaking peopleOrganoids From Breast Cancer Patients Treated With Neoadjuvant Therapy
- Where
- Pavia
- Age
- 18 years and over
- People
- 240
- Run by
- Istituti Clinici Scientifici Maugeri SpA
See details and how to joinNCT07260188 - No phaseNot yet taking people in ItalyNeutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis
- Where
- Milan
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- OncoHost Ltd.
See details and how to joinNCT07246759